Benzinga

Benzinga

Benzinga

miércoles, septiembre 02

Guardian Pharmacy Services Inc

GRDNNYSE
Trade with Public
Trade with Public
$39.52
0.651.67%
Últ. Act.: Sep 2, 1:54 PM
Fusiones y adquisiciones: Nautilus Pharmacy sold assets to Guardian Pharmacy Service (GRDN) on Tuesday, September 1, 2026
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Guardian Pharmacy Service Analyst Price Targets

Wall Street analyst price targets and consensus rating for Guardian Pharmacy Service (GRDN).

Price Target Range — 7 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$41Upside to Avg. PT+2.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026OppenheimerMichael WiederhornPT RaiseOutperform$43→$49
Jun 17, 2026Truist SecuritiesDavid MacdonaldPT RaiseBuy$43→$47
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $43 to $47.
Benzinga Newsdesk

PRO
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

B of A Securities analyst Allen Lutz maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $42 to $47.
Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $43

Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $38 to $43.
Benzinga Newsdesk

This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrades/downgrades/initiations, on Benzinga.
Avi Kapoor

PRO
B of A Securities Initiates Coverage On Guardian Pharmacy Service with Buy Rating, Announces Price Target of $42

B of A Securities analyst Allen Lutz initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Buy rating and announces Price Target of $42.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved